NewcelX Ltd
NCEL
4 hedge funds and large institutions have $1.77K invested in NewcelX Ltd in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 0 reducing their positions, and 0 closing their positions.
29,400% more capital invested
Capital invested by funds: $6 → $1.77K (+$1.76K)
300% more funds holding
Funds holding: 1 → 4 (+3)
0% less ownership
Funds ownership: 0% → 0% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.77K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$381 |
| 3 |
CIAM
Caitong International Asset Management
Hong Kong
|
+$3 |
Top Sellers
NCEL Hedge Fund Activity: Q1 2026 in Review
4 of the 8,152 institutional investors tracked by Wall St. Rank reported a position in NewcelX Ltd (NCEL) for Q1 2026, worth a combined $1.77K — up 29,400% from $6 a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NCEL positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $1.77K.
- 4 institutional investors held NewcelX Ltd (NCEL) as of Q1 2026, up from 1 in Q4 2025.
- Funds reported $1.77K of NewcelX Ltd stock for Q1 2026, up 29,400% quarter-over-quarter.
- 3 funds opened new NewcelX Ltd positions in Q1 2026 and 0 closed out, a net change of +3 holders.
- The largest NewcelX Ltd buyer in Q1 2026 was UBS Group, an estimated $1.77K added.
Based on aggregated 13F filings for Q1 2026.